CD8A and diffuse large B-cell lymphoma: Altogether, these observations suggest that, while still controversial due to technical differences, challenges and cut-off values in PD-1 detection [100,174], there is a biological connection between CD8+ PD-1+ effector T cells and DLBCL progression with potential prognostic and clinical relevance that justifies further research for this fatal disease.